Skip to main content

Table 1 Comparison of results of telepsychiatric assessments and face-to-face interviews

From: Accuracy of telepsychiatric assessment of new routine outpatient referrals

  

Sample

Accuracy Ratio Statistics

Risk Difference Statistics

Primary attributes and accuracy

A

I

Size

AR

LCI

UCI

p

RD

LCI

UCI

p

01

DSM-IV Axis 1

49

5

54

0.91

0.83

0.99

0.025

-0.09

-0.17

-0.02

0.019

02

DSM-IV Axis 2

34

3

37

0.92

0.84

1.01

0.083

-0.08

-0.17

0.01

0.071

03

DSM-IV Axis 3

36

2

38

0.95

0.88

1.02

0.157

-0.05

-0.12

0.02

0.146

04

DSM-IV Axis 4 Q1

31

6

37

0.84

0.73

0.97

0.014

-0.16

-0.28

-0.04

0.007

05

DSM-IV Axis 4 Q2

31

6

37

0.84

0.73

0.97

0.014

-0.16

-0.28

-0.04

0.007

06

DSM-IV Axis 4 Q3

37

0

37

1.00

1.00

1.00

NA

0.00

0.00

0.00

NA

07

DSM-IV Axis 4 Q4

36

1

37

0.97

0.92

1.03

0.317

-0.03

-0.08

0.03

0.311

08

DSM-IV Axis 4 Q5

37

0

37

1.00

1.00

1.00

NA

0.00

0.00

0.00

NA

09

DSM-IV Axis 4 Q6

32

5

37

0.86

0.76

0.98

0.025

-0.14

-0.25

-0.02

0.016

10

DSM-IV Axis 4 Q7

37

0

37

1.00

1.00

1.00

NA

0.00

0.00

0.00

NA

11

DSM-IV Axis 4 Q8

34

3

37

0.92

0.84

1.01

0.083

-0.08

-0.17

0.01

0.071

12

DSM-IV Axis 4 Q9

1

36

37

0.03

0.00

0.19

0.000

-0.97

-1.03

-0.92

0.000

13

DSM-IV Axis 5

26

11

37

0.70

0.57

0.87

0.001

-0.30

-0.44

-0.15

0.000

14

Risk to Self Q1

27

10

37

0.73

0.60

0.89

0.002

-0.27

-0.41

-0.13

0.000

15

Risk to Self Q2

29

8

37

0.78

0.66

0.93

0.005

-0.22

-0.35

-0.08

0.001

16

Risk to Self Q3

28

9

37

0.76

0.63

0.91

0.003

-0.24

-0.38

-0.10

0.001

17

Risk to Self Q4

28

9

37

0.76

0.63

0.91

0.003

-0.24

-0.38

-0.10

0.001

18

Risk to Others Q1

28

9

37

0.76

0.63

0.91

0.003

-0.24

-0.38

-0.10

0.001

19

Risk to Others Q2

35

2

37

0.95

0.88

1.02

0.157

-0.05

-0.13

0.02

0.146

20

Risk to Others Q3

33

4

37

0.89

0.80

1.00

0.046

-0.11

-0.21

-0.01

0.034

21

Risk to Others Q4

32

5

37

0.86

0.76

0.98

0.025

-0.14

-0.25

-0.02

0.016

22

Risk to Others Q5

33

4

37

0.89

0.80

1.00

0.046

-0.11

-0.21

-0.01

0.034

23

Risk to Others Q6

29

8

37

0.78

0.66

0.93

0.005

-0.22

-0.35

-0.08

0.001

24

Admit-Discharge-Follow-up

34

3

37

0.92

0.84

1.01

0.083

-0.08

-0.17

0.01

0.071

25

Investigations

25

12

37

0.68

0.54

0.84

0.001

-0.32

-0.48

-0.17

0.000

26

Psychological Input

26

11

37

0.70

0.57

0.87

0.001

-0.30

-0.44

-0.15

0.000

27

Community Support

29

8

37

0.78

0.66

0.93

0.005

-0.22

-0.35

-0.08

0.001

28

Drug Type

64

11

75

0.85

0.78

0.94

0.001

-0.15

-0.23

-0.07

0.000

29

Drug Action

58

17

75

0.77

0.68

0.87

0.000

-0.23

-0.32

-0.13

0.000

30

Drug Indication

49

26

75

0.65

0.55

0.77

0.000

-0.35

-0.45

-0.24

0.000

Main Attributes

31

DSM-IV Axis 1 (1)

49

5

54

0.91

0.83

0.99

0.025

-0.09

-0.17

-0.02

0.019

32

DSM-IV Axis 2 (2)

34

3

37

0.92

0.84

1.01

0.083

-0.08

-0.17

0.01

0.071

33

DSM-IV Axis 3 (3)

36

2

38

0.95

0.88

1.02

0.157

-0.05

-0.12

0.02

0.146

34

DSM-IV Axis 4 (4:12)

276

57

333

0.83

0.79

0.87

0.000

-0.17

-0.21

-0.13

0.000

35

DSM-IV Axis 5 (13)

26

11

37

0.70

0.57

0.87

0.001

-0.30

-0.44

-0.15

0.000

36

Risk to Self (14:17)

112

36

148

0.76

0.69

0.83

0.000

-0.24

-0.31

-0.17

0.000

37

Risk to Others (18:23)

190

32

222

0.86

0.81

0.90

0.000

-0.14

-0.19

-0.10

0.000

38

Admit-Discharge-Follow-up (24)

34

3

37

0.92

0.84

1.01

0.083

-0.08

-0.17

0.01

0.071

39

Investigations (25)

25

12

37

0.68

0.54

0.84

0.001

-0.32

-0.48

-0.17

0.000

40

Psychological Input (26)

26

11

37

0.70

0.57

0.87

0.001

-0.30

-0.44

-0.15

0.000

41

Community Support (27)

29

8

37

0.78

0.66

0.93

0.005

-0.22

-0.35

-0.08

0.001

42

Drug Type (28)

64

11

75

0.85

0.78

0.94

0.001

-0.15

-0.23

-0.07

0.000

43

Drug Action (29)

58

17

75

0.77

0.68

0.87

0.000

-0.23

-0.32

-0.13

0.000

44

Drug Indication (30)

49

26

75

0.65

0.55

0.77

0.000

-0.35

-0.45

-0.24

0.000

Major Attributes

45

DSM Diagnosis (1:13)

421

78

499

0.84

0.81

0.88

0.000

-0.16

-0.19

-0.12

0.000

46

Risks (14:23)

302

68

370

0.82

0.78

0.86

0.000

-0.18

-0.22

-0.14

0.000

47

Non-Drug Intervention (24:27)

114

34

148

0.77

0.71

0.84

0.000

-0.23

-0.30

-0.16

0.000

48

Drug Intervention (28:30)

171

54

225

0.76

0.71

0.82

0.000

-0.24

-0.30

-0.18

0.000

Overall

49

Overall Result (1:30)

1008

234

1242

0.81

0.79

0.83

0.000

-0.19

-0.21

-0.17

0.000

  1. A: Accurate outcome, I: Inaccurate Outcome, AR: Accuracy Ratio (Risk Ratio), LCI: Lower 95% Confidence Interval, UCI: Upper 95% Confidence Interval, RD: Risk Difference when the sample statistics compared with Accuracy (Risk) of 1 for the face-to-face interview. All approximated p values are more than zero.
  2. Numbers in brackets represent index number of primary attributes serialised in the previous rows.
  3. Drug Types- Atypical Antipsychotic, Mood Stabilizer, Tricyclic Antidepressant, Newer Antidepressant, Other Antidepressant, Benzodiazepine Group, Non-Benzodiazepine Anxolytic, Anti-Parkinsonian, and 'No Medication'.
  4. Drug related actions were grouped into 'New Prescription', 'Continuation of previously prescribed medication with no change', and 'Adjustment of previously prescribed medication'.
  5. Drug Indications were categorised for Positive Psychotic Symptoms, Manic symptoms, Bipolar Disorder, Depression, Anxiety and Associated Symptoms, Drugs for Side Effects (e.g. Anti-parkinsonian), Hypnotics, and Use of Drugs' sedative effect for anxiety control and sleep.